The authors of a new study on hospital and physician prices “use limited data to draw broad conclusions,” writes AHA Executive Vice President Tom Nickels in the AHA Stat blog. In addition to using data that represents just 13.5 percent of Americans with health coverage, he said the study fails to note that average total drug spending by hospitals per admission increased 18.5 percent between fiscal years 2015 and 2017; that hospital price and spending growth have slowed in recent years, with price growth just 1.7 percent and spending growth lower than all other categories of services; or that hospitals and health systems must manage a number of significant costs that do not apply to the physicians included in the study, among other shortcomings.

Related News Articles

Headline
The AHA submitted a statement July 11 for a Senate Special Committee on Aging hearing on health care transparency and lowering health care costs. The AHA…
Headline
Changes to the Centers for Medicare & Medicaid Services' Hospital Price Transparency Rule took effect July 1. Going forward, hospitals are required to use…
Headline
The Medicaid and CHIP Payment and Access Commission (MACPAC) June 11 released its June report to Congress. The first chapter focuses on improving the…
Headline
A blog expanding on AHA's initial response last week to the RAND Corporation's latest hospital pricing report notes, "The AHA has previously highlighted…
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
CMS March 28 released an updated online validator tool that hospitals can use to test price transparency machine-readable files against the new format and data…